CN Stock MarketDetailed Quotes

603207 Shanghai Xiao Fang Pharmaceutical

Watchlist
  • 25.81
  • -0.07-0.27%
Not Open Nov 28 15:00 CST
4.13BMarket Cap20.98P/E (TTM)

Shanghai Xiao Fang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
0.05%367.21M
0.69%261.79M
3.28%471.87M
367.01M
4.10%259.98M
3.05%123.44M
13.72%456.89M
249.74M
119.78M
11.22%401.77M
Operating revenue
0.05%367.21M
0.69%261.79M
3.28%471.87M
--367.01M
4.10%259.98M
3.05%123.44M
13.72%456.89M
--249.74M
--119.78M
11.22%401.77M
Other operating revenue
----
-8.44%150.92K
-28.57%309.77K
----
--164.84K
----
-9.41%433.69K
----
----
-25.81%478.73K
Total operating cost
2.81%179.22M
-1.49%122.12M
-6.90%240.79M
174.33M
123.96M
-0.28%258.64M
39.44%259.36M
Operating cost
0.21%125.38M
-3.23%87.54M
-12.92%162.97M
--125.11M
-12.93%90.46M
-21.32%44.09M
27.10%187.16M
--103.89M
--56.04M
11.06%147.25M
Operating tax surcharges
-7.22%2.66M
4.85%2.08M
-11.55%3.53M
--2.87M
--1.99M
----
32.92%4M
----
----
39.70%3.01M
Operating expense
7.19%30.18M
4.73%20.47M
8.50%44.5M
--28.15M
--19.55M
----
-33.46%41.01M
----
----
122.52%61.64M
Administration expense
15.15%12.39M
3.27%7.16M
9.82%14.97M
--10.76M
--6.94M
----
-59.22%13.63M
----
----
172.31%33.42M
Financial expense
-422.67%-2.06M
-743.20%-1.7M
-95.97%-1.47M
---394.75K
---201.58K
----
-373.84%-750K
----
----
-24.94%-158.28K
-Interest expense (Financial expense)
-38.63%22.68K
-36.67%16.34K
-28.31%46.93K
--36.96K
--25.8K
----
-26.95%65.46K
----
----
--89.61K
-Interest Income (Financial expense)
-351.02%-2.12M
-588.42%-1.74M
-82.52%-1.56M
---469.27K
---252.46K
----
-192.60%-856.79K
----
----
-77.21%-292.82K
Research and development
36.43%10.67M
25.30%6.56M
19.81%16.28M
--7.82M
--5.24M
----
-4.30%13.59M
----
----
24.40%14.2M
Credit Impairment Loss
-28.50%-638.04K
15.78%-1.69M
87.51%-170.95K
---496.54K
---2.01M
----
-293.95%-1.37M
----
----
1,119.66%705.81K
Asset Impairment Loss
137.00%49.2K
113.69%37.15K
66.03%-97.61K
---132.98K
---271.38K
----
-204.40%-287.31K
----
----
-544.09%-94.39K
Other net revenue
-69.52%1.09M
-138.30%-428.51K
-37.09%5.1M
3.58M
1.12M
0
-33.82%8.1M
0
0
3.69%12.24M
Fair value change income
----
-43.13%15.58K
275.88%55.14K
--41.39K
--27.4K
----
-67.54%14.67K
----
----
-64.30%45.19K
Invest income
-99.29%15.58K
----
-25.65%2.2M
--2.2M
--1.41M
----
4.54%2.96M
----
----
-22.99%2.83M
Asset deal income
----
----
----
----
----
----
--2.69K
----
----
----
Other revenue
-15.61%1.67M
-38.28%1.21M
-54.12%3.11M
--1.97M
--1.97M
----
-22.53%6.79M
----
----
14.03%8.76M
Operating profit
-3.66%189.08M
1.53%139.24M
14.45%236.18M
196.27M
25.65%137.14M
41.83%64.87M
33.43%206.36M
109.15M
45.74M
-17.31%154.66M
Add:Non operating Income
----
----
3,810.38%1M
--1M
--1M
----
5.88%25.57K
----
----
57.35%24.15K
Less:Non operating expense
3,000.77%310.08K
3,000.54%310.05K
-96.87%10K
--10K
--10K
----
139.83%318.98K
----
----
-26.19%133K
Total profit
-4.30%188.77M
0.58%138.93M
15.10%237.17M
197.26M
26.89%138.13M
42.11%64.86M
33.33%206.06M
108.86M
45.64M
-17.30%154.55M
Less:Income tax cost
-5.67%27.1M
-0.24%20.12M
8.62%33.54M
--28.73M
--20.17M
----
9.20%30.88M
----
----
4.95%28.28M
Net profit
-4.07%161.67M
0.72%118.82M
16.24%203.63M
168.53M
28.80%117.97M
41.97%55.44M
38.74%175.18M
91.59M
39.05M
-21.05%126.27M
Net profit from continuing operation
-4.07%161.67M
0.72%118.82M
16.24%203.63M
--168.53M
--117.97M
----
38.74%175.18M
----
----
-21.05%126.27M
Net profit of parent company owners
-4.07%161.67M
0.72%118.82M
16.24%203.63M
--168.53M
28.80%117.97M
41.97%55.44M
38.74%175.18M
--91.59M
--39.05M
-21.05%126.27M
Earning per share
Basic earning per share
-8.57%1.28
1.02%0.99
16.44%1.7
--1.4
--0.98
----
39.05%1.46
----
----
--1.05
Diluted earning per share
-8.57%1.28
1.02%0.99
16.44%1.7
--1.4
--0.98
----
39.05%1.46
----
----
--1.05
Other composite income
Total composite income
-4.07%161.67M
0.72%118.82M
16.24%203.63M
168.53M
117.97M
38.74%175.18M
-21.05%126.27M
Total composite income of parent company owners
-4.07%161.67M
0.72%118.82M
16.24%203.63M
--168.53M
--117.97M
----
38.74%175.18M
----
----
--126.27M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Unqualified opinion
Auditor
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 0.05%367.21M0.69%261.79M3.28%471.87M367.01M4.10%259.98M3.05%123.44M13.72%456.89M249.74M119.78M11.22%401.77M
Operating revenue 0.05%367.21M0.69%261.79M3.28%471.87M--367.01M4.10%259.98M3.05%123.44M13.72%456.89M--249.74M--119.78M11.22%401.77M
Other operating revenue -----8.44%150.92K-28.57%309.77K------164.84K-----9.41%433.69K---------25.81%478.73K
Total operating cost 2.81%179.22M-1.49%122.12M-6.90%240.79M174.33M123.96M-0.28%258.64M39.44%259.36M
Operating cost 0.21%125.38M-3.23%87.54M-12.92%162.97M--125.11M-12.93%90.46M-21.32%44.09M27.10%187.16M--103.89M--56.04M11.06%147.25M
Operating tax surcharges -7.22%2.66M4.85%2.08M-11.55%3.53M--2.87M--1.99M----32.92%4M--------39.70%3.01M
Operating expense 7.19%30.18M4.73%20.47M8.50%44.5M--28.15M--19.55M-----33.46%41.01M--------122.52%61.64M
Administration expense 15.15%12.39M3.27%7.16M9.82%14.97M--10.76M--6.94M-----59.22%13.63M--------172.31%33.42M
Financial expense -422.67%-2.06M-743.20%-1.7M-95.97%-1.47M---394.75K---201.58K-----373.84%-750K---------24.94%-158.28K
-Interest expense (Financial expense) -38.63%22.68K-36.67%16.34K-28.31%46.93K--36.96K--25.8K-----26.95%65.46K----------89.61K
-Interest Income (Financial expense) -351.02%-2.12M-588.42%-1.74M-82.52%-1.56M---469.27K---252.46K-----192.60%-856.79K---------77.21%-292.82K
Research and development 36.43%10.67M25.30%6.56M19.81%16.28M--7.82M--5.24M-----4.30%13.59M--------24.40%14.2M
Credit Impairment Loss -28.50%-638.04K15.78%-1.69M87.51%-170.95K---496.54K---2.01M-----293.95%-1.37M--------1,119.66%705.81K
Asset Impairment Loss 137.00%49.2K113.69%37.15K66.03%-97.61K---132.98K---271.38K-----204.40%-287.31K---------544.09%-94.39K
Other net revenue -69.52%1.09M-138.30%-428.51K-37.09%5.1M3.58M1.12M0-33.82%8.1M003.69%12.24M
Fair value change income -----43.13%15.58K275.88%55.14K--41.39K--27.4K-----67.54%14.67K---------64.30%45.19K
Invest income -99.29%15.58K-----25.65%2.2M--2.2M--1.41M----4.54%2.96M---------22.99%2.83M
Asset deal income --------------------------2.69K------------
Other revenue -15.61%1.67M-38.28%1.21M-54.12%3.11M--1.97M--1.97M-----22.53%6.79M--------14.03%8.76M
Operating profit -3.66%189.08M1.53%139.24M14.45%236.18M196.27M25.65%137.14M41.83%64.87M33.43%206.36M109.15M45.74M-17.31%154.66M
Add:Non operating Income --------3,810.38%1M--1M--1M----5.88%25.57K--------57.35%24.15K
Less:Non operating expense 3,000.77%310.08K3,000.54%310.05K-96.87%10K--10K--10K----139.83%318.98K---------26.19%133K
Total profit -4.30%188.77M0.58%138.93M15.10%237.17M197.26M26.89%138.13M42.11%64.86M33.33%206.06M108.86M45.64M-17.30%154.55M
Less:Income tax cost -5.67%27.1M-0.24%20.12M8.62%33.54M--28.73M--20.17M----9.20%30.88M--------4.95%28.28M
Net profit -4.07%161.67M0.72%118.82M16.24%203.63M168.53M28.80%117.97M41.97%55.44M38.74%175.18M91.59M39.05M-21.05%126.27M
Net profit from continuing operation -4.07%161.67M0.72%118.82M16.24%203.63M--168.53M--117.97M----38.74%175.18M---------21.05%126.27M
Net profit of parent company owners -4.07%161.67M0.72%118.82M16.24%203.63M--168.53M28.80%117.97M41.97%55.44M38.74%175.18M--91.59M--39.05M-21.05%126.27M
Earning per share
Basic earning per share -8.57%1.281.02%0.9916.44%1.7--1.4--0.98----39.05%1.46----------1.05
Diluted earning per share -8.57%1.281.02%0.9916.44%1.7--1.4--0.98----39.05%1.46----------1.05
Other composite income
Total composite income -4.07%161.67M0.72%118.82M16.24%203.63M168.53M117.97M38.74%175.18M-21.05%126.27M
Total composite income of parent company owners -4.07%161.67M0.72%118.82M16.24%203.63M--168.53M--117.97M----38.74%175.18M----------126.27M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion----Unqualified opinion
Auditor ----PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)----PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data